T-lymphocytes have an anti-tumor effect; however, their role is controlled by PD-1/PD-L1 axis: PD-1, expressed on surface of activated T-cells, binds to PD-L1, overexpressed in tumor cells, leading to T-cell inhibition and cancer spreading [5, 14]. This evidence concerns the gene PDCD1 and neoplasm.